KAYLA MCCRORY: Open Payments
NPI 1063276277 · CORINTH, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,150 in 95 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $1,229 · 2025 $2,150
Food & beverage: $1,697Education: $454
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $509 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $319 |
| Novartis Pharmaceuticals Corporation | 24 | $293 |
| ABBVIE INC. | 12 | $166 |
| E.R. Squibb & Sons, L.L.C. | 12 | $143 |
| GENZYME CORPORATION | 5 | $140 |
| UCB, Inc. | 5 | $127 |
| Galderma Laboratories, L.P. | 2 | $112 |
| SANOFI-AVENTIS U.S. LLC | 1 | $97 |
| LEO Pharma Inc. | 3 | $83 |
Products named: TREMFYA, DUPIXENT, COSENTYX, Sotyktu, ILUMYA, Bimzelx, NEMLUVIO, SKYRIZI.
Industry payments across MS — which companies pay providers there.
